Skip to content

Common Stock at other companies

Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
500M0.0%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's common stock?
Achieve Life Sciences (ACHV) reported common stock of $121K in Q1 2026.
How has Achieve Life Sciences's common stock changed year-over-year?
Achieve Life Sciences's common stock increased by 17.5% year-over-year, from $103K to $121K.
What is the long-term trend for Achieve Life Sciences's common stock?
Over 5 years (2020 to 2025), Achieve Life Sciences's common stock has grown at a 9.7% compound annual growth rate (CAGR), from $76K to $121K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).